UK Competition Appeal Tribunal Overturns Abuse of Dominance Fines on Pharmaceutical Companies

The UK's Competition Appeal Tribunal (the "CAT") has overturned a finding of abuse of dominance against Pfizer Inc. and Flynn Pharma Ltd. The ruling followed appeals by those companies against a 2016 Competition & Markets Authority ("CMA") decision...
By: Jones Day

Jones Day